Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial
© 2018 American Medical Association. All rights reserved. IMPORTANCE Studies of neoadjuvant chemotherapy regimens using anthracyclines followed by taxanes have reported a doubling of pathological complete remission (pCR) rates compared with anthracycline-based regimens alone. A reverse sequence did...
| Main Authors: | Gianni, L., Mansutti, M., Anton, A., Calvo, L., Bisagni, G., Bermejo, B., Semiglazov, V., Thill, M., Chacon, J., Chan, Arlene, Morales, S., Alvarez, I., Plazaola, A., Zambetti, M., Redfern, A., Dittrich, C., Dent, R., Magazzu, D., De Fato, R., Valagussa, P., Tusquets, I. |
|---|---|
| Format: | Journal Article |
| Published: |
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/69018 |
Similar Items
PEGylation of paclitaxel for inhaled chemotherapy
by: Luo, Tian
Published: (2016)
by: Luo, Tian
Published: (2016)
Preoperative CEA as a predictor of response to neoadjuvant radiotherapy
by: Mino, Jeffrey, et al.
Published: (2016)
by: Mino, Jeffrey, et al.
Published: (2016)
Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)
by: McCoy, M., et al.
Published: (2015)
Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.
by: Casciano, Fabio, et al.
Published: (2024)
by: Casciano, Fabio, et al.
Published: (2024)
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
by: Dent, R., et al.
Published: (2013)
by: Dent, R., et al.
Published: (2013)
Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
by: Fareed, Khaleel R., et al.
Published: (2012)
by: Fareed, Khaleel R., et al.
Published: (2012)
Cytotoxic effects of paclitaxel-loaded hyaluronic acid nanoparticle on selected cancer cell lines
by: Chaudhry, Gul E Saba, et al.
Published: (2016)
by: Chaudhry, Gul E Saba, et al.
Published: (2016)
Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer
by: De Nardi, Paola, et al.
Published: (2017)
by: De Nardi, Paola, et al.
Published: (2017)
Synergistic Anticancer Effects Achieved by Co-Delivery of TRAIL and Paclitaxel Using Cationic Polymeric Micelles
by: Lee, A., et al.
Published: (2011)
by: Lee, A., et al.
Published: (2011)
Synergistic effects of Gefitinib and Paclitaxel in breast cancer treatment using cockle shell-derived nanoparticle
by: Chemmalar, Sangaran
Published: (2023)
by: Chemmalar, Sangaran
Published: (2023)
Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
by: McCoy, M., et al.
Published: (2017)
by: McCoy, M., et al.
Published: (2017)
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
by: McCoy, M., et al.
Published: (2015)
by: McCoy, M., et al.
Published: (2015)
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
by: Yu, Yu, et al.
Published: (2015)
by: Yu, Yu, et al.
Published: (2015)
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
by: De Boer, R., et al.
Published: (2012)
by: De Boer, R., et al.
Published: (2012)
Induction of apoptosis and role of paclitaxel-loaded hyaluronic acid-crosslinked nanoparticles in the regulation of AKT and RhoA
by: Chaudhry, Gul E. Saba, et al.
Published: (2020)
by: Chaudhry, Gul E. Saba, et al.
Published: (2020)
The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy
by: Storr, Sarah J., et al.
Published: (2016)
by: Storr, Sarah J., et al.
Published: (2016)
Assessment of cytotoxicity potency of paclitaxel in combination with Clinacanthus Nutans extracts on human MDA-MB-231 breast cancer cells
by: Nur Hasnieza Mohd Rosli,, et al.
Published: (2018)
by: Nur Hasnieza Mohd Rosli,, et al.
Published: (2018)
Hyaluronic acid/chitosan-coated poly (lactic-co-glycolic acid) nanoparticles to deliver paclitaxel and temozolomide for oral cancer cells
by: Hassn Ali, Mesrati Malak
Published: (2022)
by: Hassn Ali, Mesrati Malak
Published: (2022)
Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines
by: Khor, Poh Yen, et al.
Published: (2021)
by: Khor, Poh Yen, et al.
Published: (2021)
Co-delivery of paclitaxel and temozolomide by CD133-B19 aptamer conjugated polyamidoamine dendrimer to U87 stem cells
by: Barzegarbehrooz, Amir
Published: (2020)
by: Barzegarbehrooz, Amir
Published: (2020)
Evaluation of retinal nerve fibre layer and macular thickness pre-and post-chemotherapy with carboplatin and paclitaxel in patients with endometrial and ovarian cancer
by: Juen, Chin Ju
Published: (2021)
by: Juen, Chin Ju
Published: (2021)
PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma
by: Luo, Tian, et al.
Published: (2016)
by: Luo, Tian, et al.
Published: (2016)
Efficacy of neoadjuvant chemotherapy in patients with oral squamous cell carcinoma in a few selected centres in Klang Valley, Malaysia / Norul Mashirah Mohd Noor
by: Norul Mashirah, Mohd Noor
Published: (2019)
by: Norul Mashirah, Mohd Noor
Published: (2019)
Nottingham clinico-pathological response index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer
by: Abdel-Fatah, T., et al.
Published: (2015)
by: Abdel-Fatah, T., et al.
Published: (2015)
Synthesis and characterization of gefitinib and paclitaxel mono and dual drug-loaded blood cockle shells (Anadara granosa)-derived aragonite CaCO3 nanoparticles
by: Chemmalar, S., et al.
Published: (2021)
by: Chemmalar, S., et al.
Published: (2021)
Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
by: Kinoshita, R., et al.
Published: (2017)
by: Kinoshita, R., et al.
Published: (2017)
Paclitaxel Inhibits Expression of Neuronal Nitric
Oxide Synthase and Prevents Mitochondrial Dysfunction in Spinal Ventral Horn in Rats After C7 Spinal Root Avulsion
by: Sim, Sze Kiat, et al.
Published: (2015)
by: Sim, Sze Kiat, et al.
Published: (2015)
The differential contribution of the innate immune system to a good pathological response in the breast and axillary lymph nodes induced by neoadjuvant chemotherapy in women with large and locally advanced breast cancers
by: Kaewkangsadan, Viriya, et al.
Published: (2017)
by: Kaewkangsadan, Viriya, et al.
Published: (2017)
Evaluate the clinical efficacy of traditional Chinese medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: a systematic review and meta-analysis
by: Tu, An, et al.
Published: (2024)
by: Tu, An, et al.
Published: (2024)
Hyaluronic acid/chitosan-coated poly (lactic-co-glycolic acid) nanoparticles to deliver single and co-loaded paclitaxel and temozolomide for CD44+oral cancer cells
by: Mesrati, Malak Hassn, et al.
Published: (2023)
by: Mesrati, Malak Hassn, et al.
Published: (2023)
Integrated Nilam And Bochord Mobile Application (I-Nab)
by: Luqman, Abdul Latif
Published: (2023)
by: Luqman, Abdul Latif
Published: (2023)
Metodologi Al-Albani Dalam $!Fat $Alat At -Nab!
by: Shabudin, Alwi
Published: (2009)
by: Shabudin, Alwi
Published: (2009)
Use of non anthracycline regimens in early stage breast cancer within Australia
by: De Boer, R., et al.
Published: (2011)
by: De Boer, R., et al.
Published: (2011)
ACA Nabs Policeman Over RM2,000 Bride
by: The Star,
Published: (2008)
by: The Star,
Published: (2008)
Investigation of nickel aluminium bronze (nab) metals cast and its properties
by: Mohd Nasuha, Ab Halim
Published: (2023)
by: Mohd Nasuha, Ab Halim
Published: (2023)
Expert: step up use of environmental forensics to nab polluters faster
by: Borneo Post Kucing
Published: (2020)
by: Borneo Post Kucing
Published: (2020)
Exceedingly biocompatible and thin-layered reduced graphene oxide nanosheets and its application in co-delivery of curcumin and paclitaxel shows highly potent synergistic anticancer effects in A549 and MDA-MB-231 cells
by: Muthoosamy, Kasturi
Published: (2016)
by: Muthoosamy, Kasturi
Published: (2016)
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4)
by: Martín, M., et al.
Published: (2017)
by: Martín, M., et al.
Published: (2017)
The prognostic and predictive power of redox rotein expression for anthracycline-based chemotherapy response in locally advanced breast cancer
by: Woolston, Caroline M., et al.
Published: (2012)
by: Woolston, Caroline M., et al.
Published: (2012)
Evaluation of immune cell infiltrates and expression of cytokines/biological molecules in the microenvironment of tumours and tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy: crucial contribution to immune-mediated tumour cell death
by: Kaewkangsadan, Viriya
Published: (2016)
by: Kaewkangsadan, Viriya
Published: (2016)
Similar Items
-
PEGylation of paclitaxel for inhaled chemotherapy
by: Luo, Tian
Published: (2016) -
Preoperative CEA as a predictor of response to neoadjuvant radiotherapy
by: Mino, Jeffrey, et al.
Published: (2016) -
Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015) -
Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.
by: Casciano, Fabio, et al.
Published: (2024) -
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
by: Dent, R., et al.
Published: (2013)